Benzodiazepine withdrawal-induced catatonia. 2001

M Deuschle, and F Lederbogen
Central Institute of Mental Health, Mannheim, Germany. deuschle@as200.zi-mannheim.de

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001960 Bromazepam One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS. Anxyrex,Apo-Bromazepam,BromaLich,Bromaz 1A Pharma,Bromazanil,Bromazep Von Ct,Bromazepam AL,Bromazepam Beta,Bromazepam Heumann,Bromazepam-Neuraxpharm,Bromazepam-Ratiopharm,Durazanil,Gen-Bromazepam,Lexatin,Lexomil,Lexotan,Lexotanil,Ro 5-3350,Apo Bromazepam,Beta, Bromazepam,Bromazepam Neuraxpharm,Bromazepam Ratiopharm,Gen Bromazepam,Ro 53350,Von Ct, Bromazep
D002389 Catatonia A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994) Catatonia, Malignant,Catatonia, Organic,Lethal Catatonia,Organic Catatonic Disorder,Schizophreniform Catatonia,Catatonia, Lethal,Catatonia, Schizophreniform,Catatonias,Catatonias, Lethal,Catatonias, Malignant,Catatonias, Organic,Catatonias, Schizophreniform,Catatonic Disorder, Organic,Catatonic Disorders, Organic,Lethal Catatonias,Malignant Catatonia,Malignant Catatonias,Organic Catatonia,Organic Catatonias,Organic Catatonic Disorders,Schizophreniform Catatonias
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents

Related Publications

M Deuschle, and F Lederbogen
August 1996, Journal of clinical psychopharmacology,
M Deuschle, and F Lederbogen
March 2023, The primary care companion for CNS disorders,
M Deuschle, and F Lederbogen
June 2022, The primary care companion for CNS disorders,
M Deuschle, and F Lederbogen
October 2014, Journal of pharmacology & pharmacotherapeutics,
M Deuschle, and F Lederbogen
October 2017, The American journal of psychiatry,
M Deuschle, and F Lederbogen
May 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
M Deuschle, and F Lederbogen
May 2019, Irish medical journal,
M Deuschle, and F Lederbogen
January 2009, Psychosomatics,
M Deuschle, and F Lederbogen
January 2016, Case reports in cardiology,
M Deuschle, and F Lederbogen
January 2001, Psychopharmacology bulletin,
Copied contents to your clipboard!